14 reports

Global Tendencies in Use of Antirheumatics ##. ## Trail from Conventional to Biological DMARDs ##. ## Global Trends of Antirheumatic Prescription ##.

  • Anti Rheumatic
  • Arthritis
  • Chronic Disease
  • Therapy
  • World

Anti-rheumatic Drugs Analysis, by Region, 2013-2022 ($MN) Table ## Global Small-Molecule Disease-Modifying Anti-rheumatic Drugs Analysis, by Test Type, 2013-2022 ($MN) Table ## Global Small-Molecule Disease-Modifying Anti-rheumatic Drugs Analysis, by End User, 2013-2022 ($

  • Anti Rheumatic
  • Asia
  • North America
  • World
  • Market Size

In more severe cases disease modifying anti-rheumatic drugs (DMARDs) may be prescribed.

  • Anti Rheumatic
  • Pathology
  • Therapy
  • United States
  • World

The initial treatment option is disease-modifying antirheumatic drugs, also known as DMARDs.

  • Anti Rheumatic
  • Monoclonal Antibody
  • Therapy
  • United States
  • World

In moderate to severe cases the treatment involves disease-modifying antirheumatic drugs (DMARDs), such as methotrexate (Rheumatrex®).

  • Anti Rheumatic
  • Monoclonal Antibody
  • Therapy
  • United States
  • World
  • 4.1 Changes to Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs, 2015-2022
  • 5.1 Abbreviations
  • Anti Rheumatic
  • Therapy
  • Japan
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Orencia may be used as monotherapy or concomitantly with diseasemodifying antirheumatic drugs (DMARDs) other than tumor necrosis factor (TNF) antagonists.

  • Anti Rheumatic
  • Monoclonal Antibody
  • World
  • Product Initiative
  • Pfizer Inc.

Anti-rheumatic Drugs (DMARDs) Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents with Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying

  • Anti Rheumatic
  • Cytokine
  • World
  • Product Initiative
  • F. Hoffmann-La Roche Ltd.

Antirheumatic Drugs (DMARDs) An Efficacy and Safety Study of Tramadol/ Acetaminophen Versus Diclofenac in the Treatment of Pain in Participants With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs) GDCT## NCT##, CR##

  • Anti Rheumatic
  • Therapy
  • World
  • Product Initiative
  • Pfizer Inc.
  • Clinical Trial profile. 73 Trial Title

Anti-rheumatic Drugs (DMARDs) Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents with Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying

  • Anti Rheumatic
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • World
  • Product Initiative

Anti-rheumatic Study of Association of Anti-inflammatory and Anti-rheumatic (ZDPC##) GDCT## NCT##, Musculoskeletal Disorders Osteoarthritis Planned Phase III Interventional Dinaflex; meloxicam Zodiac Produtos Farmaceuticos S. A.

  • Anti Rheumatic
  • Arthritis
  • Clinical Trial
  • World
  • Pfizer Inc.
  • Clinical Trial Profile Snapshots

The Impact of Antirheumatic Treatment on Antibody Response and Protection of Infections (Vaccimil) Vaccination in Inflammatory Rheumatic Disease (VACCIMIL).

  • Anti Rheumatic
  • Musculoskeletal Disorder
  • Pharmaceutical
  • World
  • Product Initiative

antirheumatic drugs (DMARDs).

  • Anti Rheumatic
  • Musculoskeletal Disorder
  • Pharmaceutical
  • United States
  • Product Initiative

antirheumatic drugs (DMARDs).

  • Anti Rheumatic
  • Musculoskeletal Disorder
  • Pharmaceutical
  • United States
  • Product Initiative